Raiffeisen Bank International Ag Biomarin Pharmaceutical Inc Transaction History
Raiffeisen Bank International Ag
- $6.6 Trillion
- Q4 2024
A detailed history of Raiffeisen Bank International Ag transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Raiffeisen Bank International Ag holds 15,658 shares of BMRN stock, worth $1.03 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,658Holding current value
$1.03 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
626Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.49 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.27 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.19 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$968 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$852 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...